Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Eric Stephen Winer, M.D.

Concepts (25)

Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Thrombocytosis12017880.560 Why?
Leukemia, Myeloid, Acute2202436090.540 Why?
Benzoates120172110.520 Why?
Hydrazines120172220.510 Why?
Deoxycytidine120178780.420 Why?
Pyrazoles1201720100.280 Why?
Geriatric Assessment1202414090.140 Why?
Molecular Targeted Therapy1202428130.110 Why?
Disease Susceptibility1202017900.100 Why?
Disease Management1202025080.080 Why?
Neoplasms12017221250.080 Why?
Combined Modality Therapy1202085190.070 Why?
Aged, 80 and over22024589460.070 Why?
Antineoplastic Agents12024136300.050 Why?
Incidence12020213570.050 Why?
Mutation12024300060.040 Why?
Prognosis12020296720.040 Why?
Aged220241692660.040 Why?
Genetic Predisposition to Disease12020178890.040 Why?
Treatment Outcome12020646700.030 Why?
Humans320247610980.020 Why?
Middle Aged120172208350.010 Why?
Adult120172210830.010 Why?
Male120173606750.010 Why?
Female120173924580.010 Why?
Winer's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (25)
Explore
_
Co-Authors (2)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.